Newly accepted in @accpchest: How I do it: Managing a Critically Ill Patient with Pulmonary Arterial Hypertension, authored by our own PH Specialist, Roxana Sulica, MD
https://t.co/rBfcA165bA
#PCCM#PulmonaryHypertension#Meded
This was my “getting killed” as a teenager. and I’ll never forgive the world for not making cymbals eat guitars the biggest New York rock band of all time.
🧵 1/ First ever AHA/ACC/multi-society guidelines re: diagnosis & management of acute PE released today!
2 year effort with 38 authors from 10 specialties.
Link attached & summary in this thread:
https://t.co/uUUyUvz3pR
A proud moment for the entire team @nyulangone: the first implant of the #BrioVAD system is now complete as part of the #INNOVATEtrial.
This milestone is about the patients who inspire this work as well as the clinicians, researchers, and engineers who push innovation into a meaningful reality. Huge congratulations and thank you to everyone who helped make this possible. Onward and upward!
#HeartFailure #ClinicalResearch #MedTech #Innovation #cardiotwitter #MedTwitter
Great insight from @msiuba presentation on invasive CO talk.
Regardless of the love/hate relationship with PAC, can’t expect change in outcomes unless there is an intervention.
If no intervention, remove PAC.
See other pearls 👇🏻
#chest2025#chestsome@accpchest@CHESTPulmCardio
One of the best albums of the decade in my opinion. A staggering bit of songwriting, sun rising over an all-night bender with people you hate trying not to come down, ecstatic exhausted and watching the gas in the tank run out. Funny and dark and moving.
https://t.co/7XAFynuR59
One of the best albums of the decade in my opinion. A staggering bit of songwriting, sun rising over an all-night bender with people you hate trying not to come down, ecstatic exhausted and watching the gas in the tank run out. Funny and dark and moving.
https://t.co/7XAFynuR59
What are the cardiopulmonary responses to and safety of performing strenuous exercise within two to four weeks postacute pulmonary embolism (PE)?
Read the original research in the September issue of #journal_CHESTPulm: https://t.co/0UKF4xEOEM
#MedEd#JournalCHEST#Pulmonary
New from our teams at @nyulangone & @BellevueHosp in @CircIntv: In intermediate-risk #PE, patients with the most severe hemodynamic derangements saw the greatest improvement after thrombectomy. Common indices may help identify super-responders.
🔗 https://t.co/3nJoKjs1ZE
#PERT
Check out our editorial wherein @ArushiSinghMD and I opine on the impact of obesity on heart #transplant outcomes. All hail #dadjokes as effective forms of communication.
Article by D Kim and J Kobashigawa:
https://t.co/ZchFYnQrO2
Our Editorial:
https://t.co/ETo9VkZdlC
🚨 Just published in @NEJM: The PIpELINe Trial 🇮🇹
👵512 pts ≥65y, ↓ physical performance 1 mo after MI
⚖️ Multidomain rehab vs usual care
❤️ CV death/unplanned hosp: 12.6% vs 20.6% (HR 0.57, p=0.01)
💪Rehab works—also in frail elderly
🔗 https://t.co/55Es7090y0
#ESC2025